Enhanced Aminos

Research Guide

Peptide Reference Guide

Every compound in our catalog, with the effects and limitations reported in publicly available preclinical and clinical literature. Use it to narrow down which compound fits a given study design.

Nothing here is medical advice, and none of these compounds are approved for human use. All items are supplied strictly for laboratory research.

06 Compounds

Fat Loss / Metabolic

Incretin agonists, lipolytic agents and metabolic modulators. The most heavily studied area of the catalog.

GLP-RT

Triple GLP-1 / GIP / Glucagon agonist

View product

A triple receptor agonist that engages GLP-1, GIP and glucagon simultaneously. Of the incretin-class molecules in circulation it is associated with the largest reported reductions in fat mass, alongside measurable shifts in glycemic markers and hepatic lipid content.

Reported benefits

  • Marked reduction in body-fat mass in trial subjects
  • Improved fasting glucose and insulin sensitivity
  • Lower hepatic steatosis markers
  • Reduced appetite and slower gastric emptying

Reported drawbacks

  • Gastrointestinal effects: nausea, vomiting, constipation, diarrhea
  • Transient elevation in resting heart rate reported
  • Lean-mass loss when protein intake is inadequate
  • Long half-life, so effects taper slowly

Available: GLP-RT10 10mg · GLP-RT15 15mg · GLP-RT20 20mg · GLP-RT30 30mg · GLP-RT60 60mg

GLP-TR

Dual GLP-1 / GIP agonist

View product

A dual agonist of the GLP-1 and GIP receptors. Research describes dose-dependent insulin secretion, suppressed glucagon output, delayed gastric emptying and pronounced appetite reduction, with fat-mass loss that scales with the titration schedule.

Reported benefits

  • Substantial fat-mass reduction
  • Improved HbA1c and fasting glucose
  • Lower caloric intake and reduced cravings
  • Favorable shifts in lipid panels

Reported drawbacks

  • Nausea, reflux and bowel changes, all dose-dependent
  • Gallbladder events associated with rapid loss
  • Muscle loss without adequate protein and loading
  • Injection-site irritation

Available: GLP-TR10 10mg · GLP-TR15 15mg · GLP-TR20 20mg · GLP-TR30 30mg · GLP-TR40 40mg · GLP-TR50 50mg · GLP-TR60 60mg

5-Amino-1MQ

Small-molecule NNMT inhibitor

View product

A small molecule that inhibits nicotinamide N-methyltransferase, an enzyme found at elevated levels in adipose tissue. Inhibition raises cellular NAD+ and SAM availability and is linked to reduced fat mass in animal models without appetite suppression.

Reported benefits

  • Fat loss independent of appetite suppression
  • May preserve or increase lean mass
  • Raises cellular NAD+ availability
  • Orally bioavailable

Reported drawbacks

  • Very limited human data
  • Long-term safety unestablished
  • Gradual, slow-building effects

Available: 5-Amino-1MQ 10mg · 5-Amino-1MQ 50mg

SLU-PP-332

ERR agonist, exercise-mimetic research compound

View product

An agonist of the estrogen-related receptors that upregulates the oxidative machinery normally triggered by training. Animal work reports gains in endurance capacity and fat oxidation without an increase in activity volume.

Reported benefits

  • Increased mitochondrial oxidative capacity
  • Improved endurance in animal models
  • Elevated fat oxidation
  • Effect seen without added training volume

Reported drawbacks

  • Rodent data only, no human trials
  • Optimal dose range unclear
  • Long-term safety profile unknown

Available: SLU-PP-332 5mg

Lemon Bottle

Lipolytic solution for localized fat research

View product

A multi-component lipolytic solution studied for site-specific fat reduction. Research focuses on localized adipocyte breakdown rather than systemic metabolic change.

Reported benefits

  • Site-specific lipolysis in models
  • Non-surgical approach to localized adiposity
  • Rapid onset of visible change
  • Well established in cosmetic research settings

Reported drawbacks

  • Swelling, erythema and tenderness at the site
  • Limited controlled literature
  • Outcome depends heavily on technique

Available: Lemon Bottle 10ml

MS10

Metabolic signalling compound

View product

An early-stage metabolic signalling compound studied for cellular energy regulation, lipid metabolism and receptor-level modulation of energy homeostasis. Its mechanism differs from the incretin agonists, which makes it useful as a comparison arm in metabolic study designs.

Reported benefits

  • Investigated for effects on basal metabolic rate
  • Studied in lipid metabolism pathways
  • May influence cellular ATP homeostasis
  • Non-incretin mechanism for comparative designs

Reported drawbacks

  • Very early-stage research only
  • Receptor binding profile still being characterized
  • No human data and no established dose range
  • Limited published literature

Available: MS10 10mg

04 Compounds

Focus / Mood / Sleep

Neuropeptides studied for cognition, stress response and sleep architecture.

Semax

Synthetic ACTH(4-10) analog

View product

A heptapeptide derived from ACTH that modulates BDNF expression and dopaminergic and serotonergic signalling. Most commonly researched for attention, learning and neuroprotection.

Reported benefits

  • Improved focus, memory and learning in studies
  • Upregulated BDNF and NGF expression
  • Neuroprotective in ischemic models
  • Reported anxiolytic effect

Reported drawbacks

  • Short half-life, often dosed intranasally
  • Stimulatory profile can disrupt sleep if dosed late
  • Most human data originates outside the US and EU

Available: Semax 10mg

Selank

Tuftsin-derived anxiolytic heptapeptide

View product

A synthetic analog of the immunopeptide tuftsin, studied for anxiety reduction without sedation or dependence. Research points to GABA and serotonin modulation plus cytokine regulation.

Reported benefits

  • Anxiolytic effect without sedation
  • Improved cognition under stress
  • Modulates immune cytokine signalling
  • No withdrawal reported

Reported drawbacks

  • Effects described as subtle by some subjects
  • Short half-life
  • Limited Western clinical data

Available: Selank 10mg

DSIP

Delta sleep inducing peptide

View product

A nonapeptide originally isolated from cerebral venous blood during induced sleep. Studied for sleep onset, restoration of circadian rhythm and stress-axis modulation.

Reported benefits

  • Deeper, more restorative sleep architecture
  • May lower cortisol output
  • Mild analgesic activity
  • Supports circadian normalization

Reported drawbacks

  • Response varies considerably between subjects
  • Short half-life
  • Few high-quality human trials

Available: DSIP 10mg

TSM

Targeted synaptic modulator

View product

A cognitive research peptide investigated for its influence on synaptic function, neuroplasticity and neuronal signalling. It sits in the emerging nootropic class, studied for neuroprotective pathways and cognitive performance in preclinical models.

Reported benefits

  • Investigated for support of synaptic plasticity and LTP
  • Research interest in BDNF pathway engagement
  • Studied for reduction of microglial neuroinflammation
  • May support neuronal energy metabolism

Reported drawbacks

  • Preclinical stage, no human trials
  • Blood-brain barrier penetration still under investigation
  • Dose-response relationship not established
  • Long-term safety profile unknown

Available: TSM 10mg

03 Compounds

Hormone / GH Support

Growth-hormone secretagogues and GHRH analogs used to study the somatotropic axis.

Tesamorelin

GHRH(1-44) analog

View product

A stabilized analog of growth-hormone-releasing hormone. Research centres on visceral adipose tissue reduction and IGF-1 elevation through endogenous GH release rather than exogenous GH administration.

Reported benefits

  • Reduced visceral adipose tissue
  • Elevated IGF-1 via endogenous GH release
  • Preserved lean mass during fat loss
  • Studied for cognitive and hepatic markers

Reported drawbacks

  • Injection-site reactions common
  • Possible fluid retention and joint discomfort
  • IGF-1 requires monitoring over long protocols
  • Blunted response in subjects with high baseline GH

Available: Tesamorelin 10mg · Tesamorelin 20mg

CJC1295 + Ipamorelin

GHRH analog with selective GH secretagogue

View product

A pairing of a modified GHRH analog with a selective ghrelin-receptor secretagogue. The two act on different pathways, producing a larger and more physiological GH pulse than either alone.

Reported benefits

  • Amplified GH pulse versus either compound alone
  • Selective GH release with limited effect on cortisol and prolactin
  • Supports recovery and sleep quality
  • Reduced injection-site irritation with the modified analog

Reported drawbacks

  • Pituitary response declines with sustained use
  • Transient flushing and head pressure possible
  • Requires consistent dosing schedule
  • Elevated appetite reported with the secretagogue component

Available: CJC1295 + Ipamorelin 10mg

PT-141

Melanocortin receptor agonist

View product

A cyclic analogue of alpha-MSH studied for central melanocortin signalling rather than vascular effects. Research interest sits in hypothalamic MC4R activity and the desire pathways downstream of it.

Reported benefits

  • Studied for central nervous system pathway activity
  • High-affinity MC4R binding in receptor assays
  • Engagement of dopamine-linked reward signalling
  • Cyclic structure resists enzymatic degradation

Reported drawbacks

  • No long-term safety data
  • Receptor subtype selectivity still being mapped
  • Response varies widely between models
  • Transient blood pressure changes reported in early work

Available: PT-141 10mg

04 Compounds

Longevity / Specialty

Mitochondrial, telomere and cellular-energy research compounds.

NAD+

Nicotinamide adenine dinucleotide

View product

A coenzyme central to redox metabolism, mitochondrial ATP production and sirtuin signalling. Endogenous levels decline with age, which is the basis for most longevity research using it.

Reported benefits

  • Supports mitochondrial energy production
  • Feeds DNA repair through sirtuin and PARP pathways
  • May improve clarity and endurance
  • Broad metabolic support

Reported drawbacks

  • Subcutaneous administration can sting or flush
  • Infusion protocols are time intensive
  • Cost rises quickly at higher doses

Available: NAD+ 500mg · NAD+ 1000mg

MOTS-c

Mitochondrial-derived metabolic peptide

View product

A 16-amino-acid peptide encoded in the mitochondrial genome. It regulates metabolic homeostasis and insulin sensitivity through AMPK activation and is studied for exercise capacity.

Reported benefits

  • Improved insulin sensitivity
  • Greater endurance and metabolic flexibility
  • Supports favorable body composition
  • Promotes mitochondrial biogenesis

Reported drawbacks

  • Limited long-term human data
  • Best studied alongside a training stimulus
  • Effects modest without metabolic stress

Available: MOTS-c 10mg · MOTS-c 20mg · MOTS-c 40mg

SS-31

Mitochondria-targeted tetrapeptide

View product

An elamipretide-class tetrapeptide that concentrates inside the inner mitochondrial membrane and stabilizes cardiolipin. Studied mainly in models of mitochondrial dysfunction and ischemia-reperfusion.

Reported benefits

  • Reduced mitochondrial reactive oxygen output
  • Improved ATP efficiency
  • Protection in ischemia-reperfusion models
  • Studied for age-related mitochondrial decline

Reported drawbacks

  • Data largely preclinical
  • Short half-life requiring frequent dosing
  • Clinical trial results mixed

Available: SS-31 10mg

Epithalon

Telomerase-associated tetrapeptide

View product

A synthetic tetrapeptide modeled on epithalamin from the pineal gland. Research focuses on telomerase activation, melatonin rhythm and markers of cellular aging.

Reported benefits

  • Reported preservation of telomere length
  • Improved sleep and melatonin rhythm
  • Antioxidant and immune-supportive effects
  • Favorable geroprotective markers in models

Reported drawbacks

  • Long-term human data limited
  • Cumulative and subtle effects
  • Requires extended protocols

Available: Epithalon 10mg

06 Compounds

Recovery / Healing

Repair-focused compounds studied for connective tissue, angiogenesis and inflammation control.

BPC-157

Body protection compound

View product

A pentadecapeptide derived from gastric juice protein. It is one of the most researched repair peptides, with models covering tendon, muscle, gut lining and gastric ulcer healing.

Reported benefits

  • Accelerated tendon and muscle repair in models
  • Angiogenic support for tissue healing
  • Gastroprotective effect
  • Modulates inflammatory signalling

Reported drawbacks

  • Almost entirely animal data
  • Half-life measured in minutes
  • Optimal route still debated

Available: BPC-157 10mg

TB-500

Thymosin beta-4 fragment

View product

A synthetic fragment of thymosin beta-4 that promotes actin regulation and cell migration. Studied for flexibility, wound closure and recovery from strain injuries.

Reported benefits

  • Improved tissue flexibility and mobility
  • Faster wound closure in models
  • Supports new blood vessel formation
  • Reduced scar formation

Reported drawbacks

  • Limited controlled human trials
  • Effects build slowly
  • Possible fatigue at higher doses

Available: TB-500 10mg

Wolverine Stack

BPC-157 with TB-500

View product

A pre-mixed pairing of the two best-known repair peptides. The combination is studied for the complementary pathways it covers: local tissue repair alongside systemic cell migration and remodelling.

Reported benefits

  • Broad repair coverage from two mechanisms
  • Convenient single-vial protocol
  • Supports both tendon and muscle recovery
  • Synergistic angiogenic effect in models

Reported drawbacks

  • Fixed ratio limits independent titration
  • Preclinical evidence only
  • Higher per-protocol cost

Available: Wolverine Stack 20mg

IGF-1LR3

Long-arginine insulin-like growth factor 1

View product

An extended-half-life analog of IGF-1 with reduced binding-protein affinity. Studied for muscle protein synthesis, nutrient partitioning and cellular growth signalling.

Reported benefits

  • Increased protein synthesis in muscle tissue
  • Improved nutrient partitioning
  • Enhanced recovery between sessions
  • Longer activity window than native IGF-1

Reported drawbacks

  • Hypoglycemia risk requires careful timing
  • Possible connective tissue stress at high doses
  • Limited long-term safety data

Available: IGF-1LR3 1mg

KPV

Anti-inflammatory tripeptide

View product

A tripeptide fragment of alpha-MSH with concentrated anti-inflammatory activity. Researched primarily in gut inflammation, skin conditions and immune signalling.

Reported benefits

  • Reduced inflammatory cytokine output
  • Supports gut barrier integrity
  • Studied for skin inflammation models
  • No melanocortin pigmentation effects

Reported drawbacks

  • Very short half-life
  • Limited human data
  • Narrow scope of action

Available: KPV 10mg

ARA-290

Non-erythropoietic EPO-derived peptide

View product

A short peptide derived from erythropoietin that retains its tissue-protective signalling without stimulating red blood cell production. Studied for neuropathy and inflammation-driven damage.

Reported benefits

  • Tissue-protective without raising hematocrit
  • Studied in diabetic neuropathy models
  • Reduced neuroinflammation
  • Well tolerated in early trials

Reported drawbacks

  • Modest effect sizes in published trials
  • Short half-life
  • Limited availability of long-term data

Available: ARA-290 10mg

04 Compounds

Beauty / Wellness

Compounds studied for skin architecture, pigmentation, oxidative load and cellular aesthetics.

GHK-Cu

Copper tripeptide-1

View product

A copper-binding tripeptide found naturally in human plasma, where levels fall with age. Research covers collagen synthesis, elastin production, wound remodelling and hair follicle signalling.

Reported benefits

  • Stimulates collagen and elastin synthesis
  • Improved skin firmness and density
  • Supports hair follicle activity
  • Broad gene-expression reset in aged tissue

Reported drawbacks

  • Blue-green tint and copper taste at the site
  • Can irritate sensitive skin in high concentrations
  • Effects require weeks of consistent use

Available: GHK-Cu 50mg · GHK-Cu 100mg

Glutathione

Master intracellular antioxidant

View product

The body’s principal endogenous antioxidant, central to detoxification, redox balance and melanin regulation. Studied for oxidative load reduction and skin clarity.

Reported benefits

  • Reduces oxidative stress load
  • Supports hepatic detoxification pathways
  • Studied for even skin tone
  • Recycles vitamins C and E

Reported drawbacks

  • Short half-life in circulation
  • Poor oral absorption, injection preferred in research
  • Effects fade quickly after protocols end

Available: Glutathione 1500mg

Glow

GHK-Cu, BPC-157 and TB-500 blend

View product

A cosmetic-focused blend pairing the copper peptide with two repair peptides. Designed to combine collagen support with faster tissue remodelling for skin-focused research.

Reported benefits

  • Combined collagen and repair signalling
  • Supports skin texture and tone
  • Faster recovery from cosmetic insult
  • Single-vial convenience

Reported drawbacks

  • Fixed ratios limit customization
  • Limited data on the specific combination
  • Higher cost than single compounds

Available: Glow 70mg

Klow

Multi-peptide aesthetic blend

View product

A four-component blend formulated for skin quality and localized fat research. Each vial carries four independently assayed peptides, all verified in the corresponding certificate of analysis.

Reported benefits

  • Multiple aesthetic pathways in one vial
  • Each component independently assayed
  • Supports skin quality alongside contour research
  • Reduces total injection volume

Reported drawbacks

  • Fixed ratios cannot be adjusted
  • Combination-specific data is limited
  • Premium price point

Available: Klow 80mg

Research Use Only

The information on this page summarizes published research and is provided for educational purposes only. It is not a claim of efficacy, safety or intended use for any product sold by Enhanced Aminos. All compounds are sold strictly for in vitro laboratory research and are not for human or veterinary consumption.

Terms & Conditions / Legal Notice

All products sold by Enhanced Aminos are intended strictly for in vitro research and laboratory use only. These compounds are not approved by the FDA and are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease or medical condition.

By purchasing, you confirm that you are a qualified researcher and will use these compounds solely for lawful scientific research purposes. You must be 21 years of age or older to purchase. Enhanced Aminos reserves the right to refuse service to anyone.

All sales are final. Enhanced Aminos assumes no liability for misuse, improper handling, or any damages arising from the use of these research compounds. Prices and availability are subject to change without notice.

Enhanced Aminos

© 2026 Enhanced Aminos. For Research Purposes Only. Not For Human Consumption.

Contact Us